GEFFEN RESIDENCE & RENEWAL LTD Inactive Instrument
Geffen Residence & Renewal Ltd Share Price TEL AVIV STOCK EXCHANGE
Equities
GEFR
IL0011181166
Real Estate Development & Operations
| Sales 2022 | 0.06 0.22 5 | Sales 2023 | 0.14 0.53 11.83 | Capitalization | 101M 373M 8.39B |
|---|---|---|---|---|---|
| Net income 2022 | -20M -74.16M -1.67B | Net income 2023 | -6M -22.25M -500M | EV / Sales 2022 | 1,06,75,41,950 x |
| Net Debt 2022 | 1.54M 5.71M 128M | Net Debt 2023 | 14.22M 52.73M 1.19B | EV / Sales 2023 | 80,93,08,493 x |
| P/E ratio 2022 |
-3.11
x | P/E ratio 2023 |
-14.6
x | Employees | - |
| Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 49.8% |
More Fundamentals
* Assessed data
More news
| Managers | Title | Age | Since |
|---|---|---|---|
Moshe Koren
CEO | Chief Executive Officer | 60 | - |
Yossi Hatan
DFI | Director of Finance/CFO | 45 | - |
Daniel Spira
AUD | Comptroller/Controller/Auditor | 69 | 03/16/03 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Ami Barlev
BRD | Director/Board Member | 45 | - |
| Director/Board Member | 44 | - | |
Moshe Koren
CEO | Chief Executive Officer | 60 | - |
Geffen Residence & Renewal Ltd, formerly known as Cannomed Medical Cannabis Industries Ltd, is an Israel-based company which is primarily engaged in real estate industry. Geffen Residence & Renewal Ltd has recently changed its general activity from cannabis industry into real estate. The main activity is divided into two business areas such as, real estate investment and urban renewal. The Company poses two residential apartments for rent in Kiryat Ono and Carmel Castle. Despite the fact that Geffen Residence & Renewal Ltd has undergone a change in the main activity it still owns one pharmacy in the city of Petah Tikva. Geffen Residence & Renewal Ltd operates exclusively in the country of Israel.
| 1st Jan change | Capi. | |
|---|---|---|
| +40.41% | 29.49B | |
| -11.60% | 27.43B | |
| +7.86% | 27.14B | |
| +20.90% | 26.59B | |
| +49.25% | 23.87B | |
| +13.23% | 21.03B | |
| -1.52% | 19.01B | |
| +28.90% | 16.66B | |
| -13.27% | 15.27B |
